ELEmmanuel Laffitte

Emmanuel Laffitte

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Emmanuel Laffitte has a total of 125 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Swiss S1 Guidelines for the Management of Hidradenitis Suppurativa

    by Antonios G.A. Kolios, Emmanuel Laffitte, Carlo Mainetti, Francesco Messina, Jöri Pünchera, Peter Schiller, Florian Anzengruber, Severin Läuchli, Seyed Morteza Seyed Jafari, Karolina Reiprich, et al.

    Hidradenitis suppurativa (HS) is a chronic, inflammatory skin condition characterized by painful nodules, abscesses, and sinus tracts, causing significant physical and psychological distress. The profound impact of HS underscores the need for comprehensive management strategies to enhance patient outcomes and quality of life. This S1 guideline, developed by the Swiss HS Foundation, provides evidence-based recommendations for systemic and surgical treatments in HS, emphasizing the importance of standardized care practices. It incorporates insights and an informal expert consensus of Swiss dermatologists and dermatosurgeons. The guideline addresses conventional therapies, such as antibiotics and retinoids, as well as emerging biological treatments and surgical interventions, offering a holistic approach to managing this challenging disease.

  • Small Fiber Neuropathy in Long COVID: A Cohort Study with Multimodal Assessment and Follow-Up

    by Natalia Drobinska, Mayssam Nehme, Fréderic Assal, Emmanuel Laffitte, Idris Guessous, Agustina M. Lascano

    Introduction: Given the increasing number of patients suffering from pain associated with dysautonomic symptoms following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, we aimed to estimate the occurrence of small fiber neuropathy (SFN) in a cohort of long coronavirus disease 19 (COVID-19) patients reporting postinfectious neuropathic pain. Methods: The study cohort included 18 patients suffering from neuropathic pain (neuropathic pain score DN4 ≥4) appearing after or during SARS-CoV-2 infection and lasting ≥90 days; presenting normal nerve conduction studies excluding large fiber damage. Patients underwent multimodal SFN evaluation by skin biopsy, quantitative sensory testing (QST), laser evoked potential (LEP) recording and electrochemical skin conductance (ESC; Sudoscan). Results: Out of 18 patients, 17 were analyzed. Participants’ ages averaged 44 ± 9 years, with 94% females. Fourteen (82%) had abnormal skin biopsy results. Notably, 12/17 (70%) patients presented with autonomic complaints, all of whom had abnormal skin biopsy results. At 6-month follow-up, 10/17 patients reported a subjective improvement in pain and/or dysautonomia with or without symptomatic pharmacological or non-pharmacological treatment. In our cohort, QST showed the highest sensibility (79%) and specificity (67%), followed by LEP (sensibility 71%, specificity 67%). ESC showed poor reliability in the screening of SFN with a sensibility of 7% and specificity of 50%. Conclusion: The results of our study suggest that SFN may develop during or shortly after SARS-CoV-2 infection, provoking disabling sensory and dysautonomic symptoms that tend to persist for more than 6 months. Furthermore, our findings imply that noninvasive exams are a useful complement to biopsy in the diagnostic process of SFN.


  • Open Access

    Newsletter No. 30

    by Vincenzo Bettoli, Alessandro Borghi, Stefania Zauli, Giulia Toni, Michela Ricci, Silvia Giari, Annarosa Virgili, A. Dompmartin, Beatrice Amann‐Vesti, Thomas Meier, et al.

  • Open Access

    Front & Back Matter

    by Vincenzo Bettoli, Alessandro Borghi, Stefania Zauli, Giulia Toni, Michela Ricci, Silvia Giari, Annarosa Virgili, A. Dompmartin, Beatrice R. Amann-Vesti, Thomas O. Meier, et al.